Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial.
- DOI
- 10.1016/s0140-6736(26)00205-9
- Published
- 2026 Apr 4
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-26-00205-9,
title = {Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial.},
author = {Holck EN and Holm NR and Hildick-Smith D and Lindsay MM and Spence MS and Erglis A and Menown IBA and Steigen T and Hune Mogensen LJ and Modrau IS and Niemelä M and Lassen JF and Oldroyd K and Stradins P and Walsh SJ and Endresen PC and Trovik T and Fröbert O and Graham ANJ and Anttila V and Trivedi U and Thuesen L and Christiansen EH},
year = {2026},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(26)00205-9},
url = {https://doi.org/10.1016/s0140-6736(26)00205-9}
}RIS
TY - JOUR TI - Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial. AU - Holck EN AU - Holm NR AU - Hildick-Smith D AU - Lindsay MM AU - Spence MS AU - Erglis A AU - Menown IBA AU - Steigen T AU - Hune Mogensen LJ AU - Modrau IS AU - Niemelä M AU - Lassen JF AU - Oldroyd K AU - Stradins P AU - Walsh SJ AU - Endresen PC AU - Trovik T AU - Fröbert O AU - Graham ANJ AU - Anttila V AU - Trivedi U AU - Thuesen L AU - Christiansen EH PY - 2026 JO - Lancet (London, England) DO - 10.1016/s0140-6736(26)00205-9 UR - https://doi.org/10.1016/s0140-6736(26)00205-9 ER -
APA
EN, H., NR, H., D, H., MM, L., MS, S., A, E., IBA, M., T, S., LJ, H. M., IS, M., M, N., JF, L., K, O., P, S., SJ, W., PC, E., T, T., O, F., ANJ, G., V, A., U, T., L, T., & EH, C. (2026). Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)00205-9
Source records
- pubmed · retrieved 2026-09-25T14:42:41.136Z